Michael Kors Clutch Uk
CAMBRIDGE, Mass. Securities and Exchange Commission ("SEC") relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by Genocea Biosciences, Inc. The number of shares to be offered and the price range for the offering have not yet been determined.
Genocea Biosciences Files For 75 Michael Kors Crossbody Gold
About Genocea Biosciences, Inc.
The offering will be made only by means of a prospectus.
cell vaccines includes GEN 003 for HSV 2 therapy, GEN 004, and earlier stage programs in chlamydia, HSV 2 prophylaxis and malaria.
Genocea is harnessing the power of T cell immunity to develop the next generation of vaccines. T cells are increasingly recognized as a critical element of protective immune responses to a wide range of infectious disease pathogens, but are difficult to target using traditional vaccine discovery methods. Genocea is able to identify protective T cell antigens in humans exposed to a pathogen using ATLAS, its proprietary technology platform, potentially enabling vaccines against pathogens for which vaccine solutions do not exist or are sub optimal. Genocea's pipeline of novel T Michael Kors Purse Navy
Genocea Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
Citigroup and Cowen and Company are acting as joint book running managers for the offering. Stifel, Nicolaus Company, Incorporated is acting as lead manager and Needham Company, LLC is acting as co manager.
Genocea Biosciences's Herpes Simplex Virus Vaccine Heads for Critical Proving Ground Biotech Retrophin, LLC (RTRX) Files For $40 Million IPO
Help employers find you! Check out all the .
Genocea Biosciences Publishes Preclinical Data for Investigational Vaccine Candidate for HSV 2 Rare Disease Drug Developer Ultragenyx Pharmaceuticals Jumps Toward $86 Million IPO
Genocea Biosciences Selected to Present Late Breaking Oral Presentation Michael Kors Clutch Uk at ICAAC 2013 San Diego's Vital Therapies, Inc. (VTI) Postpones IPO As Biotech Sector Cools Off
Genocea Biosciences Initiates Phase 1 Study Of Vaccine Candidate GEN 004 To Prevent Infections Caused By Pneumococcus Eagle Pharmaceuticals Files For A $50 Million IPO
an offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
A registration statement relating to these securities has been filed with the SEC, but has not yet become effective. These securities may not be sold and offers to buy may not be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy and there shall not be any sale of these securities in any state or jurisdiction in which such Michael Kors Hamilton Traveler Review
Michael Kors Clutch Uk
Michael Kors Wallet
Michael Kors Bags Brown And White
Handbag Michael Kors
New Balance 730 V2
Michael Kors Purse Tote
Michael Kors Greenwich
Blue New Balance Cleats
Michael Kors Ava Saffiano
Michael Kors Jet Set Navy
Michael Kors Crossbody Navy Blue
New Balance 446 Trainers
New Balance High Top Basketball Shoes
New Balance Shoes Us Made
Michael Kors Selma Black Tote Bag
Michael Kors Purses Dillards